Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
10/2008
10/15/2008EP1314979B1 Method and device for determining state of skin surface
10/15/2008EP0918546B1 Improvements in or relating to contrast agents
10/15/2008CN101287503A Methods and compositions for diagnosis of iga-and igm-mediated kidney diseases
10/15/2008CN101287502A Compositions and methods for treating HIV infection with cupredoxin and cytochrame c
10/15/2008CN101284139A Medicine intestinal tract preparation before abdominopelvic cavity CT detection and preparation method thereof
10/15/2008CN101284138A Preparation method of chronic liver injury unit stress depression rat model
10/14/2008US7437195 Regulation of eating habits
10/14/2008US7435870 administering nucleic acids to fish and detecting changes in messenger RNA in the cells, tissues or organs using a cDNA microarray, in response to the nucleic acids; screening drugs for neovscularization, apoptosis or toxic activity
10/14/2008US7435554 Immunoglobulin specific to lung cancer cell surface protein for use as tool in detection and treatment of cell proliferative disorders; immunotherapy; immunodiagnostics; antitumor agents
10/14/2008US7435415 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC)
10/14/2008US7435380 Dispensed from a spray bottle
10/14/2008CA2339244C Methods of ophthalmic administration
10/14/2008CA2304461C Lipophilic metal complexes for necrosis and infarction imaging
10/14/2008CA2300147C Sol-gel coated polarization vessels
10/09/2008WO2008121346A1 Methods for identifying compounds that modulate neurotrophic factor signaling
10/09/2008WO2008121153A2 Dendrimers and methods of making and using thereof
10/09/2008WO2008119493A1 Composition of labeled and non-labeled monoclonal antibodies
10/09/2008WO2008119181A1 Stabilized gold nanoparticles and methods of making the same
10/09/2008WO2008082736A3 Compositions and methods of their use for improving the condition and appearance of skin
10/09/2008WO2008057370A3 Means and methods for cytometric therapies
10/09/2008WO2008048675A3 Treatment for age-related macular degeneration and other diseases of the eye
10/09/2008WO2008008463A3 METHODS AND COMPOSITIONS FOR DETECTING AND QUANTIFYING SAPPβ
10/09/2008WO2007109335A3 A method for noninvasively and quantitatively monitoring therapeutic and diagnostic transgene expression induced by ex vivo and in vivo gene targeting in organs, tissues and cells
10/09/2008US20080250512 Generating sleep disorder animal model via administering plasma constituents recovered from renal failure patients diagnosed with restless legs and /or periodic limb movement disorders
10/09/2008US20080249298 use of heparinoid derivatives for the treatment and diagnosis of disorders which can be treated with heparinoids
10/09/2008US20080248566 Matriptase, a serine protease and its applications
10/09/2008US20080247958 Prevents tissue injuries in mammals; hypovolemic conditions such as capillary leak syndrome and shock
10/09/2008US20080247957 Administering injectable, echogenic nanocapsule and/or microcapsule comprising drug, targeting moiety, or both; biodegradation
10/09/2008US20080247956 Identification of novel factors that block programmed cell death or apoptosis by targeting jnk
10/09/2008US20080247955 Detecting secreted phosphoprotein-1 and/or biomarkers; autoimmune diseases; antibodies; RNA interference
10/09/2008US20080247954 Especially oxazole, thiazole and imidazole compounds 2-substituted with phenyl -cycloalkyl or -bicycloalkyl groups; drug screening
10/09/2008US20080247953 Drug screening assays; SH2 docking domains; signal sequences; immunology; cyclophilins
10/09/2008US20080247952 Method for Quantifying a Cholinergic Neurotoxin in a Sample
10/09/2008US20080247951 Angiogenesis inhibition
10/09/2008US20080247950 Proteases of human kallikrein 2 (hK2); tissue imaging
10/09/2008US20080247943 Emulsion containing high boiling fluorocarbon; particles coated with lipid, surfactant
10/09/2008US20080247625 Method and System for Leading Macromolecule Substances into Living Target Cells
10/09/2008CA2682513A1 Stabilized gold nanoparticles and methods of making and using the same
10/09/2008CA2681790A1 Composition of labeled and non-labeled monoclonal antibodies
10/08/2008EP1978015A1 Precursor compound of radioactive halogen labeled organic compound
10/08/2008EP1977768A1 Dental paste composition having X-Ray imaging property
10/08/2008EP1977727A1 Composition for dyeing dental plaque for evaluating dental caries activity
10/08/2008EP1976850A1 Novel lanthanide ligands and complexes, and use thereof as contrast agents
10/08/2008EP1976568A2 Test method for assessing irritation of skin
10/08/2008EP1976515A2 Combination therapy with parp inhibitors
10/08/2008EP1401505B1 A population of hoxb8 mutants and uses in identifying agents for treating repetitive behaviors
10/08/2008EP1337264B1 A nutritional dietary system, formulation, kit and method for use in preparing an individual for a predetermined activity
10/08/2008CN101281810A Surface finished magnetic nano crystal dry powder with activated oxatyl and preparation method thereof
10/08/2008CN101279098A Method for preparing cellulose contrast medium for stomach and intestine ultrasonic imaging
10/08/2008CN101279093A Cancer modulation antibody
10/07/2008USRE40535 Light and heavy chains of given amino acid sequence; bind to antigen; radiolabeled; adminstration for diagnosis and treatment of cancer
10/07/2008US7432397 Imaging compounds
10/07/2008US7431925 Internal image antibodies for optical imaging and therapy
10/07/2008US7431915 Peptides whose uptake by cells is controllable
10/07/2008CA2338646C Microparticles with adsorbent surfaces, methods of making same, and uses thereof
10/07/2008CA2250219C Materials and methods for making improved liposome compositions
10/02/2008WO2008119036A2 Compositions for targeted imaging and therapy
10/02/2008WO2008118364A1 Methods of modeling migraine pain and identifying candidate compounds for the treatment of migraine
10/02/2008WO2008118143A2 Verifiable hand cleansing formulation and method
10/02/2008WO2008117646A1 Method for stabilization of antibody
10/02/2008WO2008116293A1 Multivalent heterobifunctional polymers and methods of their use
10/02/2008WO2008033031B1 Mri trackable drug delivery particles, uses and methods thereof
10/02/2008WO2007143076A3 Nanoparticles and coated nanoparticles
10/02/2008WO2007126938A3 Marker for chromosomal abnormalities
10/02/2008WO2007118245A8 Methods and compositions related to adenoassociated virus-phage particles
10/02/2008WO2006107814A3 Methods for measuring the metabolism of neurally derived biomolecules in vivo
10/02/2008US20080242974 Method and apparatus to hyperpolarize materials for enhanced mr techniques
10/02/2008US20080241873 Multi-use multimodal imaging chelates
10/02/2008US20080241232 Use of green porphyrins to treat neovasculature in the eye
10/02/2008US20080241074 Multi-use multimodal imaging chelates
10/02/2008US20080241073 contrast agent circulates in blood for long period and targets solid tumors for clear image; block polymer of hydrophilic polymer chain amidated with a carboxy polymer chain (amino acid) which binds to chelating agent, coordinated gadolinium atoms, and a polyamine; polyethylene glycol-polyaspartic block
10/02/2008US20080241072 Injectable void filler for soft tissue augmentation
10/02/2008US20080241071 Quantum Dot Probes
10/02/2008US20080241070 Fenofibrate dosage forms
10/02/2008US20080241069 Methods and compositions for treating IgE-mediated diseases
10/02/2008US20080241068 Assaying reaction ( swelling, irritation and erythema) of fluoropyrimidine selected from 5-FU, capecitabine, tegafur, tegafur-uracil, floxuridine, 5-fluorodeoxyuridine, S-1 to the skin of an indivisual for determination the toxicity of fluoropyridmine or has a dihydropyrimidine dehydrogenase deficiency
10/02/2008US20080241067 co-culturing cancer cells and host cells for a time sufficient to detect evidence of gene expression in co-culture for simulating the progression from a primary tumor to a metastasis in an in vitro model; anti-EphA2 ( epithelial cell kinase) antibody
10/02/2008US20080241066 Anti-PRL-3 antibodies and methods of use thereof
10/02/2008DE102007015598A1 Verwendung von fluorhaltigen Verbindungen zu Diagnosezwecken mit Hilfe bildgebender Verfahren Using fluorine-containing compounds for diagnostic purposes using imaging techniques
10/02/2008CA2682064A1 Compositions for targeted imaging and therapy
10/02/2008CA2681766A1 Multivalent heterobifunctional polymers and methods of their use
10/02/2008CA2681764A1 Methods of modeling migraine pain and identifying candidate compounds for the treatment of migraine
10/02/2008CA2681567A1 Method of preparing an immunologically-active adjuvant-bound dried vaccine composition
10/01/2008EP1974686A2 Apparatus for applying a biopsy site marker
10/01/2008EP1973575A2 Biocompatible fluorescent metal oxide nanoparticles
10/01/2008EP1765162A4 Contrast agents for magnetic resonance imaging
10/01/2008CN100422180C Amyloid plaque aggregation inhibitors and diagnostic imaging agents
09/2008
09/30/2008US7429387 Administering neurotoxin
09/30/2008US7429381 Production and use of novel peptide-based agents for use with bi-specific antibodies
09/30/2008US7429374 Determining if a batch of glatiramer acetate is acceptable for pharmaceutical use
09/30/2008CA2263425C Pharmaceutical agent containing rho kinase inhibitor
09/30/2008CA2190509C Hepatocyte-selective oil-in-water emulsion
09/30/2008CA1341581C Leukaemia inhibitory factor
09/25/2008WO2008114801A1 Pet visualization of amyloid-associated neuroinflammation in the brain
09/25/2008WO2008113185A1 Antagonists of ligands and uses thereof
09/25/2008WO2008094598A3 Method and system for determining cardiac function
09/25/2008WO2008088648A3 Methods and compositions for improved f-18 labeling of proteins, peptides and other molecules
09/25/2008WO2008085518A3 Compositions and methods relating to organ-, tissue-, and cell-specific antibodies
09/25/2008WO2007077531A8 Quinaldine based semisquaraines and squaraine dyes, process for preparation thereof and use thereof
09/25/2008US20080233194 Stabilized ; dispersion in dispersion microstructure; administering to lungs
1 ... 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 ... 354